Skip to main content
Governance & Risk

AI Act Conformity Assessment

A conformity assessment under the EU AI Act is the procedure by which a high-risk AI system is verified to meet the regulation's requirements (Articles 8–15) before being placed on the EU market or put into service.

AIDOLS Research Team · Editorial standards

Full definition

Two paths exist: (1) internal conformity assessment (Annex VI) — the provider self-assesses against the regulation, used for most Annex III high-risk systems; (2) third-party assessment by a notified body (Annex VII) — mandatory for Annex III biometric systems when the provider has not fully applied harmonised standards or common specifications (with them, it may choose Annex VI instead); AI built into Annex I products, such as medical devices, follows the notified-body procedure of that product law, with the AI Act requirements and parts of Annex VII folded in (Article 43(3)). Successful conformity yields a CE marking and EU declaration of conformity, plus, for Annex III systems, registration in the EU AI database. Substantial modifications trigger reassessment.

Why it matters

Conformity assessment is the gate between developing a high-risk AI system and lawfully selling it in the EU. Cycle time and cost must be in every product timeline and budget.

Example

A medical-device manufacturer integrates AI triage into its product; because the device falls under MDR, it requires third-party notified-body assessment combining MDR and AI Act Annex VII before CE marking.

Next steps

More governance & risk terms

Source & further reading

Primary source: European Union — Regulation (EU) 2024/1689 on Artificial Intelligence (Articles 43, Annex VI-VII) (2024).

Citation policy: this entry is part of the AIDOLS AI Implementation Glossary and may be quoted for research, journalism, and education with attribution to aidolsgroup.com/en/glossary/ai-act-conformity-assessment/.